This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HanAll Biopharma Co., Ltd.
Drug Names(s): HL032, HL-032, Engineered human growth hormone
Description: HL032 is a protease resistant and orally available human growth hormone. Using high throughput Resistein technology, parent molecules are modified by amino acid substitution to produce resistance to proteases in tissue, serum and GI track while maintaining or significantly improving their PK/PD profile.
Additional information available to subscribers only: